All fields · Transplantation

JournalQ1· SCImago 2025

American Journal of Transplantation

ISSN 1600-6135

• Q1Quartile
• 3.00SJR
• 238h-index
• 14papers summarised

About this journal

American Journal of Transplantation is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 3.00 and an h-index of 238. Most of its papers in the Pofolia pool fall under Transplantation. Pofolia holds AI summaries of 14 paper(s) from this journal; the most cited is “Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody…” (932 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?

Papers we summarise from this journal

• Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant2012 · 932 citations
• OPTN/SRTR 2016 Annual Data Report: Kidney2018 · 502 citations
• An economic assessment of contemporary kidney transplant practice2018 · 447 citations
• OPTN/SRTR 2015 Annual Data Report: Kidney2017 · 443 citations
• OPTN/SRTR 2019 Annual Data Report: Kidney2021 · 370 citations
• Assessment of Tocilizumab (Anti–Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients2017 · 356 citations
• Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial2012 · 329 citations
• OPTN/SRTR 2017 Annual Data Report: Kidney2019 · 327 citations
• OPTN/SRTR 2011 Annual Data Report: Kidney2012 · 308 citations
• Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression2014 · 279 citations
• The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics2023 · 263 citations
• Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury2013 · 263 citations
• Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys2012 · 263 citations
• Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation2012 · 240 citations

Journals in the same field

See every journal in the field →